
Chinese manufacturing and commercial company of Novo Nordisk, the Danish pharmaceutical group headquartered in Bagsværd. Produces insulin and other injectable medicines at its Tianjin plant and markets Novo Nordisk's diabetes, obesity, haemophilia and growth disorder treatments in China, supported by local research and development and clinical operations.
Để lại đánh giá